Nausea is an unpleasant feeling that occurs within the pit of the stomach due to various reasons, which ultimately causes vomiting. This could be due to motion sickness, pregnancy, untreated diseases, a warning symptom of chronic disease, cancer-related seizures and anxiety. Several home remedies and over-the-counter medications can slow down the urge to vomit while feeling nauseated.
One popular anti-nausea medicine is Pepto Bismol which contains bismuth salicylate that relieves gastric acid. Emetrol is another medication that has no side effects and effectively stops the feeling of vomiting. These drugs are sold often to bring relief over an upset stomach; hence the nausea medicine market has seen a considerable rise.
Nausea Medicine Market Size
The Global Nausea Medicine industry is projected to grow from USD 3.66 Billion in 2024 to USD 6.24 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.20% during the forecast period (2024 - 2032).
Nausea Medicine Market Share
The North American market sees a sharp rise in nausea medicine segmentation due to morning sickness related to pregnancy among many women, cancer treatment, awareness and diagnosis of chronic ailments. The Europe market is driven by gastroenteritis cases being the sole cause of present morbidity rates.
The Asia Pacific market is also widely driven by gastric conditions, especially children. With the domination of the older population, it has been noted that nausea medicine sales have increased over the past few years. The Middle East and African regions have been dormant when it comes to selling these medicines. It has been slow regarding awareness among the masses that rely on homemade remedies.
The key companies investing in the nausea medicine market are Pfizer, GlaxoSmithKline, ANI Pharmaceuticals, Inc., Merck & Co. Inc., Sanofi, TESARO Inc., and F.Hoffmann-La Roche Ltd.
Nausea Medicine Market Growth
Symptoms of nausea were observed among the population undergoing chemotherapy for cancer-related conditions. There has been a growth of rotavirus among children aged less than five years in the Asia Pacific regions which causes acute gastric distress, thus giving the rise in sales of anti-nausea drugs. Countries like India and China have noted that sudden lifestyle change has caused unhealthy eating habits leading to various gastro infections. Due to the advancement of medicines and pharma collaborations with developing countries, the nausea medicine market is emerging in these developing countries.
Stomach ulcers and food poisoning are also common causes for a disturbed stomach, resulting in the production of large-scale nausea medications.
Nausea Medicine Market Value
The nausea medicine market development is based on end-user type, which defines pharmaceutical companies and hospitals stocking these drugs. The mode of administration market is segmented into the IV through administration into the human body and over the counter tablets. The basis for the indication depends on morning movements and nausea, seasickness, chemotherapy and other symptoms associated with the illness. Based on the types sold on the market, it depends on antacids, anxiety medications, steroids, and dopamine antagonists. Thus, all these administrations and end-users’ channels drive the nausea medicine market globally.
Industry News
It was observed that the novel coronavirus harmed the health system and that one of the symptoms of this pandemic virus was vomiting. To counter this, there has been an increase in the sale of drugs for nausea and the delivery of home remedies. Thus, the future for treatments associated with nausea will see an increase due to unhealthy diet plans and an erratic working lifestyle.
For More Information, Please Visit @ Market Research Future
